FR2622108B1 - PREPARATION OF PROCONVERTINE CONCENTRATES (FACTOR VII), ANTIHEMOPHILIC FACTOR B (FACTOR IX) AND OTHER PLASMA PROTEINS, AND THEIR THERAPEUTIC USE - Google Patents

PREPARATION OF PROCONVERTINE CONCENTRATES (FACTOR VII), ANTIHEMOPHILIC FACTOR B (FACTOR IX) AND OTHER PLASMA PROTEINS, AND THEIR THERAPEUTIC USE

Info

Publication number
FR2622108B1
FR2622108B1 FR8714665A FR8714665A FR2622108B1 FR 2622108 B1 FR2622108 B1 FR 2622108B1 FR 8714665 A FR8714665 A FR 8714665A FR 8714665 A FR8714665 A FR 8714665A FR 2622108 B1 FR2622108 B1 FR 2622108B1
Authority
FR
France
Prior art keywords
factor
proconvertine
concentrates
preparation
therapeutic use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8714665A
Other languages
French (fr)
Other versions
FR2622108A1 (en
Inventor
Catherine Michalski
Thierry Burnouf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LILLE TRANSFUSION SANGUINE
Original Assignee
LILLE TRANSFUSION SANGUINE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LILLE TRANSFUSION SANGUINE filed Critical LILLE TRANSFUSION SANGUINE
Priority to FR8714665A priority Critical patent/FR2622108B1/en
Priority to AT88402643T priority patent/ATE84543T1/en
Priority to ES88402643T priority patent/ES2045167T5/en
Priority to EP88402643A priority patent/EP0317376B2/en
Priority to DE3877529T priority patent/DE3877529T2/en
Priority to DK198805877A priority patent/DK173859B1/en
Priority to NO884688A priority patent/NO179997C/en
Priority to JP63267004A priority patent/JP2768957B2/en
Publication of FR2622108A1 publication Critical patent/FR2622108A1/en
Application granted granted Critical
Publication of FR2622108B1 publication Critical patent/FR2622108B1/en
Priority to US07/683,109 priority patent/US5457181A/en
Priority to GR930400157T priority patent/GR3006910T3/en
Priority to FR95C0026C priority patent/FR95C0026I2/fr
Priority to GR960401282T priority patent/GR3019900T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR8714665A 1987-10-23 1987-10-23 PREPARATION OF PROCONVERTINE CONCENTRATES (FACTOR VII), ANTIHEMOPHILIC FACTOR B (FACTOR IX) AND OTHER PLASMA PROTEINS, AND THEIR THERAPEUTIC USE Expired - Lifetime FR2622108B1 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR8714665A FR2622108B1 (en) 1987-10-23 1987-10-23 PREPARATION OF PROCONVERTINE CONCENTRATES (FACTOR VII), ANTIHEMOPHILIC FACTOR B (FACTOR IX) AND OTHER PLASMA PROTEINS, AND THEIR THERAPEUTIC USE
ES88402643T ES2045167T5 (en) 1987-10-23 1988-10-20 PREPARATION OF HUMAN FACTOR IX CONCENTRATE OF HIGH PURITY AND OTHER PLASMA PROTEINS.
EP88402643A EP0317376B2 (en) 1987-10-23 1988-10-20 Preparation of a concentrate of high-purity human factor IX and of other plasma proteins
DE3877529T DE3877529T2 (en) 1987-10-23 1988-10-20 Production of highly purified human factor IX and other plasma protein concentrate and its therapeutic use.
AT88402643T ATE84543T1 (en) 1987-10-23 1988-10-20 PRODUCTION OF HIGHLY PURIFIED HUMAN FACTOR IX AND OTHER PLASMAPROTEIN CONCENTRATE AND THERAPEUTIC USE THEREOF.
NO884688A NO179997C (en) 1987-10-23 1988-10-21 Process for the preparation of therapeutically useful Factor IX concentrate with high purity
DK198805877A DK173859B1 (en) 1987-10-23 1988-10-21 Process for Preparation of a Highly Purified Human Factor IX Concentrate and Other Plasma Proteins
JP63267004A JP2768957B2 (en) 1987-10-23 1988-10-22 High purity human factor IX concentrates and other plasma proteins and their therapeutic use
US07/683,109 US5457181A (en) 1987-10-23 1991-04-11 Preparation of a high-purity human factor IX concentrate and other plasmatic proteins and their therapeutic use
GR930400157T GR3006910T3 (en) 1987-10-23 1993-01-28 Preparation of a concentrate of high-purity human factor IX and of other plasma proteins
FR95C0026C FR95C0026I2 (en) 1987-10-23 1995-06-27
GR960401282T GR3019900T3 (en) 1987-10-23 1996-05-13 Preparation of a concentrate of high-purity human factor IX and of other plasma proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8714665A FR2622108B1 (en) 1987-10-23 1987-10-23 PREPARATION OF PROCONVERTINE CONCENTRATES (FACTOR VII), ANTIHEMOPHILIC FACTOR B (FACTOR IX) AND OTHER PLASMA PROTEINS, AND THEIR THERAPEUTIC USE

Publications (2)

Publication Number Publication Date
FR2622108A1 FR2622108A1 (en) 1989-04-28
FR2622108B1 true FR2622108B1 (en) 1990-03-02

Family

ID=9356101

Family Applications (2)

Application Number Title Priority Date Filing Date
FR8714665A Expired - Lifetime FR2622108B1 (en) 1987-10-23 1987-10-23 PREPARATION OF PROCONVERTINE CONCENTRATES (FACTOR VII), ANTIHEMOPHILIC FACTOR B (FACTOR IX) AND OTHER PLASMA PROTEINS, AND THEIR THERAPEUTIC USE
FR95C0026C Active FR95C0026I2 (en) 1987-10-23 1995-06-27

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR95C0026C Active FR95C0026I2 (en) 1987-10-23 1995-06-27

Country Status (1)

Country Link
FR (2) FR2622108B1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE15489T1 (en) * 1980-05-27 1985-09-15 Miles Lab BLOOD COAGULATION ACTIVATING PRODUCT AND PROCESS FOR PRODUCTION.
AT368883B (en) * 1980-07-22 1982-11-25 Immuno Ag METHOD FOR PRODUCING A NEW HUMAN PROTEIN-BASED PREPARATION PROCESSING BLOOD

Also Published As

Publication number Publication date
FR95C0026I2 (en) 1996-11-08
FR2622108A1 (en) 1989-04-28
FR95C0026I1 (en) 1996-06-21

Similar Documents

Publication Publication Date Title
IL91843A0 (en) Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids
IL76441A (en) Blood coagulation inhibiting proteins and their preparation
DK478786D0 (en) CYSTEIN-DEFINED MUTEINS OF BIOLOGICALLY ACTIVE HUMAN TUMOR NECROCESS FACTOR PROTEINS
ZA896468B (en) Lyophilization of red blood cells
DE3877529D1 (en) MANUFACTURE OF HIGHLY-LOST HUMAN FACTOR IX AND OTHER PLASMA PROTEIN CONCENTRATE AND THEIR THERAPEUTIC USE.
FR2579596B1 (en) (IMIDAZOLYL-4) PIPERIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
SE8501050D0 (en) BIOLOGICALLY ACTIVE FRAGMENTS OF HUMAN ANTIHEMOPHILIC FACTOR AND METHOD FOR PREPARATION THEREOF
BE896993A (en) FACTORS 1,2,3,4 and 5 OF TEICHOMYCIN A2, THEIR PREPARATION AND THEIR USE
FR2577557B1 (en) PEPTIDES AND PEPTIDE DERIVATIVES, THEIR PREPARATION, THEIR THERAPEUTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AU2157888A (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
PH25149A (en) Cyclic peptides and their preparation
MC1337A1 (en) INTERFERON OF HUMAN FIBROBLASTS IN THE FORM OF A HOMOGENEOUS PROTEIN AND ITS PREPARATION
MC1884A1 (en) HIRUDINE VARIANTS, THEIR USE AND THEIR PREPARATION
IL83347A0 (en) Recombinant htlv-iii proteins and their use
DK141090A (en) PREPARATION OF HUMAN PROUROKINASE
FR2622108B1 (en) PREPARATION OF PROCONVERTINE CONCENTRATES (FACTOR VII), ANTIHEMOPHILIC FACTOR B (FACTOR IX) AND OTHER PLASMA PROTEINS, AND THEIR THERAPEUTIC USE
YU219289A (en) Recombinant hybride proteins of interleucine-2
NZ224393A (en) Recombinant hiv envelope proteins and uses thereof
PT85560A (en) Human low affinity fc epsylon-receptor the isolation the recom-binant preparation and purification thereof
IL91771A0 (en) Increased expression of small molecular weight recombinant proteins
FR2598707B1 (en) NOVEL SURFACTANTS, THEIR PREPARATION AND THEIR USE
ZA883878B (en) Human immunodeficiency virus gag-encoded proteins
ZA893085B (en) Human immunodeficiency virus(hiv)env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
ZA897509B (en) Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids
KR860014160U (en) Oriental medicine and physical therapy clothing

Legal Events

Date Code Title Description
CP Supplementary protection certificate (spc) filed

Free format text: PRODUCT NAME: FACTEUR IX; NAT. REGISTRATION NO/DATE: NL19762 19941230; FIRST REGISTRATION: FR - NL19762 19941230

Spc suppl protection certif: 95C0026

Filing date: 19950627

CP Supplementary protection certificate (spc) filed

Free format text: 95C0026, 950627

CR Request for supplementary protection certificate laid open to the public (eec regulation of 18 june 1992)

Free format text: 95C0026, 950627

CY Supplementary certificate of protection granted (eec regulation of 18 june 1992)

Free format text: 95C0026, 950627, EXPIRES:20091230

CP Supplementary protection certificate (spc) filed
CA Change of address

Spc suppl protection certif: 95C0026

CD Change of name or company name

Spc suppl protection certif: 95C0026

TP Transmission of property

Spc suppl protection certif: 95C0026